NASR et al., “Computer Assisted Structure-Anticancer Activity Correlations of Carbamates and Thiocarbamates”, Journal of Pharmaceutical Sciences, pp. 831-836, (1985), American Pharmaceutical Association. |
Atassi, et al., “R17934-NSC 238159: A New Antitumor Drug”, pp. 599-607, (1975), Europ. J. Cancer, vol. 11, Pergamon Press. |
Aur, “Treatment of Parasitic Infestation in Children with Malignant Neoplams” pp. 129-131, (1971), The Journal of Pediatrics, vol. 78, No. 1, Mosby, Inc. |
Bissery, et al., “Docetaxel in Vivo Combination Chemotherpy”, pp. 3-16, (1995), Seminars in Oncology, vol. 22, No. 6-S13, W.B. Saunders Company. |
Brabender, et al., “The Effects of Methyl[5-(2-Thienylcarbonyl)-1H-benzimidazol-2-yl]carbamate, (R 17934; NSC 238159, a New Antitumoral Drug Interfering with Microtubules”, pp. 905-916, (1976), Cancer Research, vol. 36, American Assoication of Cancer Research. |
Brown, et al., “Antiparasitic Drugs. IV. 2-(4′-Thiazolyl)-Benzimidazole, A New Anthelmintic”, pp. 1764-1765, (1961), Journal of American Chemical Society., American Chemical Society. |
Carter et al., “Drug-Tumor Interactions”, pp. 362-365, (1981), Chemotherapy of Cancer, 2nd Ed., John Wiley & Sons. |
Carter, “2-(α-Hydroxybenzyl)-Benzimidazole”, pp. 277-346, (1975), Selective Inhibitors of Viral Functions, CRC Press, Inc. |
Chimeno, Process for the perparation of alkyl N'-alkylcarbamoyl-N-(2-benizimidazolyl) carbamates, (1987), Chemical Abstracts 107:39817, American Chemical Society. |
Delatour, et al., “Embryotoxic and Antimitotic Properties in the Benzimidazole Series”, pp. 505-515, (1976), Therapie, vol. 31, No. 4, John Libbey & Co., Ltd., (English translation thereof). |
DuPont, “‘Benlate’ Fungicide”, pp. 1-9, (1994), Material Safety Data Sheet, DuPont. |
Elgebaly, et al., “Reversal of gamma-Radiation-Induced Leukemogenesis in Mice by Immunomodulation with Thiabendazole and Dinitrofluorobenzene”, pp. 811-815 (1985), Chemical Abstracts 102:217569, American Chemical Society. |
Elgebaly, et al., “Reversal of gamma-Radiation-Induced Leukemogenesis in Mice by Immunomodulation with Thiabendazole and Dinitrofluorobenzene”, pp. 811-815 (1985), J. Natl. Cancer Inst., Oxford University Press. |
Friedman, et al., “Interaction of Anthelmintic and Benzimidazole Derivaives with Bovine Brain Tubulin”, pp. 605-614, (1978), Biochimica et Biophysica Acta, Elsevier/North-Holland Biomedical Press. |
Georgopapadakov, et al., “Human Mycoses: Drugs and Targets for Emerging Pathogens”, pp. 371-373, (1994), Science, vol. 264, American Association for the Advancement of Science. |
Ghannoum, et al., “Combinations of antifungal and antineoplastic drugs with interactive effects on inhibition of yeast growth”, pp. 308-320, (1990), Chemical Abstracts 113:112365, American Chemical Society. |
Graubaum, et al., “Acylation of Heterocycles with Carbonic Acid Derivatives”, pp. 809-815, (1982), Chemical Abstacts 98:52877, American Chemical Society. |
Grenda, et al., “Novel Preparation of Benzimidazles from N-Arylamidines. New Synthesis of Thiabendazole”, pp. 259-261, (1965), Journal Organic Chemistry, vol., 30, Academic Press. |
Katiyar, et. al., “Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence”, pp. 2086-2090, (1994), Chemical Abstracts 121:175012z, American Chemical Society. |
Lacey, et al., “Activity of Benzimidazole Carnmates against L1210 Mouse Leukaemia Cells” Correlation with in vtiro Tubulin Polymerization Assay, pp. 3603-3605 (1985), Biochemical Pharmacology, vol. 34, No. 19, Pergamon Press Ltd. |
Lacey, et al., “Structure-Activity Relationships of Benzimidazole Carbmates as Inhibitors of Mammalian Tubulin, in vitro”, pp. 1073-1077 (1985), Biochemical Pharmacology, vol. 34, No. 7, Pregamon Press Ltd. |
Lacey, et al., “The Role of the Cytoskeletal Protein, Tubulin, in the Mode of Action and Mechanism or Drug Resisteance to Benzimidazoles”, pp. 885-936, (1988), International Journal for Parasitology, vol. 18, No. 7, Pergamon Press Ltd. |
Lapras, et al. “Experimental Study of the Potential Anticancerous Properties of Parbendazole (SKF 29044)”, pp. 379-397, (1975), Bull. Soc. Sci. Vet. et Med. comparee, Lyon, vol. 77, No. 6, Societe des Sciences veterinaries et de Medecine comparee de Lyon, (in French)—and English translation thereof. |
Lessnau, et al., “Disseminated Stronglyloides stercoralis in Human Immunodeficiency Virus-infected Patients”, pp 119-122, (1993), Chest, vol. 104, American College of Chest Physicians. |
Lovett, “Immunomodulating Effects of Thiabendazole: Immunotherapeutic Efficacy in the Treatment of Murine Fibrosarcoma”, pp. 5315-5316, (1979), Dissertation Abstracts International, Health Science, Immunology, vol. 39, No. 11, U M I. |
Lundy, et al., “Chemoimmunotherapy of a murine fibrosarcoma: critical factors for success of combined modality therapy”, pp. 339-345, (1997), Chemical Abstracts 87:161659, American Chemical Society. |
Lundy, et al., “Immunomodulation with Thiabendazole: A Review of Immunologic Properties and Efficacy in Combined Modality Cancer Therapy”, pp. 1955-1962, (1978), Cancer Treatments Reports, vol. 62, No. 11, U.S. Department of Health, Education, and Welfare. |
Lundy, et al., “Thiabendazole: A New Immunopotentiator Effective in Therapy of Murine Fibrosarcoma”, pp. 132-134, (1976), Surgical Forum, Vol. 27, No. 62, American College of Surgeons. |
Marinovich, et al., “Mixtures of Benomyl, Primiphos-Methyl, Dimethoate, Diazinon and Azinphos-Methyl Affect Protein Synthesis in HL-60 Cells Differently”, pp 173-85, (1994), Toxicol., vol. 94, Elsevier Science Ireland Ltd. |
Menzel, et al., “Effects of some systemic fungicides on viral multiplication”, pp. 353-362, (1979), Chemical Abstracts 92:123231, American Chemical Society. |
The Merck Index, Twelfth Edition, “7943: 'Procodazole”, p. 1333, and “9877: 'Triprolidine”, pp. 1660-1661, (1996), Merck Research Laboratories. |
The Merck Index, Eighth Edition, “Thiabendazole”, p. 1035, (1968), Merck & Co., Inc. |
Nene, et al., “Systemic Fungicides”, pp. 208-386, (1993), Fungicides in Plant Disease Control, Third Edition, Ch. 9, International Science Publisher. |
Private Communication to Dr. Von Hoff from National Institute of Health, National Cancer Society ( Sep. 18, 1995). |
Ram, et al., “Synthesis and Biological Activity of Certain Alkyl 5-(Alkoxycarbonyl)-1H-Benzimidazole-2-carbmates and Realted Derivatives: A New Class of Potential Antineoplastic and Antifilarial Agents”, pp. 539-547, (1992), Journal of Medicinal Chemistry, vol. 35, No. 3, American Chemical Society. |
Stedman's Medical Dictionary, 24th Edition, “Leukemia”, pp. 777-778, (1983), Williams & Wilkins. |
Tanneberg, et al., “Substituted Benzimidazolecarbmates”, p. 7, (1985), Chemical Abstracts 102:24617, American Chemical Society. |
Teicher, et al., “Potentiation of Cytotxic Therapies by TNP-470 and Minocycline in Mice Bearing EMT-6 Mammary Carcinoma”, pp 227-236, (1995), Breast Cancer Research and Treatment, vol. 36, Kluwer Academic Publishers. |
Thomson, “Fungicides”, pp. 154, 121, 123, (1993-1994 Revision), Agricultural Chemicals Book IV, Thomson Publications. |
Vergieva, “Carbendazim teratogenic activity of rats”, pp. 333-339, (1982) Chemical Abstracts 98:66765, American Chemical Society. |
Pending Application of Camden, Ser. No. 09/264,942, filed Mar. 9, 1999. (5638D2C). |
Pending Application of Camden, Ser. No. 09/375,173, filed Aug. 16, 1999. (5702CR). |
Pending Application of Camden, Ser. No. 09/469,389, filed Dec. 22, 1999. (5703D2C). |
Pending Application of Camden, Ser. No. 09/360,499, filed Jul. 26, 1999. (5781D). |
Pending Application of Camden, Ser. No. 08/674,182, filed Jul. 16, 1996, CPA filed Feb. 10, 1999. (5782). |
Pending Application of Camden, Ser. No. 09/371,457, filed Aug. 10, 1999. (5784R). |
Pending Application of Camden, Ser. No. 09/371,459, filed Aug. 10, 1999. (5784R2). |
Pending Application of Camden, Ser. No. 09/364,021, filed Jul. 30, 1999. (5785D2). |
Pending Application of Camden, Ser. No. 09/312,948, filed May 17, 1999. (5786D). |
Pending Application of Camden, Ser. No. 09/394,383, filed Sep. 10, 1999. (5786DR). |
Pending Application of Camden, Ser. No. 09/218,884, filed Dec. 22, 1998. (6496D). |
Pending Application of Camden, Ser. No. 08/857,811, filed May, 16, 1997, CPA filed Jul. 28, 1999. (6643). |
Pending Application of Camden, Ser. No. 09/312,949, filed May 17, 1999. (7161R). |
Pending Application of Camden, Ser. No. 09/374,717, filed Aug. 13, 1999. (7719). |
Pending Application of Camden, Ser. No. 09/462,243, filed Jan. 05, 2000 (6642). |
Pending Application of Camden, Ser. No. 09/552,408, filed Apr. 19, 2000. (6496D2). |
Pending Application of Camden, Ser. No. 09/552,825, filed Apr. 20, 2000. (6643D2). |
Pending Application of Camden, Ser. No. 09/552,820, filed Apr. 20, 2000. (6643D3). |
Pending Application of Camden, Ser. No. 09/560,059, filed Apr. 27, 2000. (5781D3). |
Pending Application of Camden, Ser. No. 09/603,040, filed Jun. 26, 2000. (5781DC). |
Pending Application of Camden, Ser. No. 09/791,986, filed Apr. 28, 2000. (8068). |
Pending Application of Camden, Ser. No. 09/562,709, filed Apr. 28, 2000. (8069). |
Pending Application of Camden, Ser. No. 09/602,170, filed Jun. 22, 2000. (5783C2). |
Pending Application of Camden, Ser. No. 09/603,322, filed Jun. 26, 2000. (5781D2). |
Pending Application of Camden, Ser. No. 09/618,990, filed Jul. 18, 2000. (5702CRD). |
Pending Application of Camden, Ser. No. 09/639,188, filed Aug. 15, 2000 (5784R2D). |
Pending Application of Camden, Ser. No. 09/640,148, filed Aug. 16, 2000 (5784R2C). |
Pending Application of Camden, Ser. No. 09/645,708, filed Aug. 24, 2000 (5785D2RD). |
Pending Application of Camden, Ser. No. 09/645,427, filed Aug. 24, 2000 (5785D2RD2). |
Pending Application of Camden, Ser. No. 09/640,920, filed Aug. 17, 2000 (7161R2). |
Pending Application of Camden, Ser. No. 09/640,918, filed Aug. 17, 2000 (7161R3). |
Pending Application of Camden, Ser. No. 09/640,919, filed Aug. 17, 2000 (7161R4). |
Pending Application of Camden, Ser. No. 09/676,407, filed Sep. 29, 2000 (6643R). |
Pending Application of Camden, Ser. No. 09/676,034, filed Sep. 29, 2000 (6643R2). |
Pending Application of Camden, Ser. No. 09/676,033, filed Sep. 29, 2000 (6643R3). |
Pending Application of Camden, Ser. No. 09/676,409, filed Sep. 29, 2000 (6643R4). |
Pending Application of Camden, Ser. No. 09/676,032, filed Sep. 29, 2000 (6643R5). |
Pending Application of Camden, Ser. No. 09/676,031, filed Sep. 29, 2000 (6643R6). |
Pending Application of Camden, Ser. No. 09/676,030, filed Sep. 29, 2000 (6643R7). |
Pending Application of Camden, Ser. No. 09/676,029, filed Sep. 29, 2000 (6643R8). |
Pending Application of Camden, Ser. No. 09/676,408, filed Sep. 29, 2000 (6643R9). |
Pending Application of Camden, Ser. No. 09/676,202, filed Sep. 29, 2000 (6643R10). |
Pending Application of Camden, Ser. No. 09/670,169, filed Sep. 26, 2000 (8250). |
Pending Application of Camden, Ser. No. 09/670,168, filed Sep. 26, 2000 (8251). |
Pending Application of Camden, Ser. No. 09/670,170, filed Sep. 26, 2000 (8252). |
Pending Application of Camden, Ser. No. 09/670,166, filed Sep. 26, 2000 (8253). |
Pending Application of Camden, Ser. No. 09/703,955, filed Nov. 01, 2000 (8315). |
Pending Application of Camden, Ser. No. 09/737,835, filed Dec. 12, 2000 (5782C). |
Pending Application of Camden, Ser. No. 09/748,651, filed Dec. 22, 2000 (5638D2CD). |
Pending Application of Camden, Ser. No. 09/748,652, filed Dec. 22, 2000 (5785D2RC). |